Elvia Adriana Morales

Prof. Elvia Adriana Morales

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2021 in Journal of Analytical Methods in Chemistry
Verified
Journal Article
Open access
PDF file
EMEsmeralda Mota-Lugo
Esmeralda Mota-Lugo
MDMariana Dolores-Hernández
Mariana Dolores-Hernández
EMElvia Adriana Morales
Elvia Adriana Morales
IBIris A. Blanco-Alcántara
Iris A. Blanco-Alcántara
HCHugo Cuatecontzi-Flores
Hugo Cuatecontzi-Flores
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
trans-Resveratrol, a phytochemical compound with antioxidant power and various therapeutic effects, such as cardioprotective, chemopreventive, and neuroprotective, among others, has disadvantages of poor solubility and limited stability, creating difficulties for the development of new strategies for its quantification. This study developed and validated an analytical stability method for trans-resveratrol by high-pressure liquid chromatography with photodiode-array detection (HPLC-PDA), which allowed its quantification in the presence of its degradation products. The quantification of trans-resveratrol occurred at a retention time of 2.6min, with ammonium formate (10mM, pH=4)/acetonitrile, 70/30v/v, as mobile phase. The validation met the ICH Q2 criteria of specificity, method linearity (2.84.2μg/ml), precision and accuracy, robustness, quantification limit (0.176μg/ml), and detection (0.058μg/ml). As degradation products, cis-resveratrol was observed at 3.9min, which could be resveratrone in 3.2min and five unidentified products in 0.7, 1.0, 1.4, 1.8, and 5min. Some solutions subjected to temperature stress of 40 and 60°C, UV light, and acidic and basic hydrolysis exhibited colour changes. An analytical method was obtained by HPLC-PDA, which allowed quantifying the stability of trans-resveratrol in a fast and specific manner in the presence of its degradation products.

24 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BSBruno Solís-Cruz
Bruno Solís-Cruz
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
EMElvia Adriana Morales
Elvia Adriana Morales
Guillermo TellezGuillermo Tellez
Guillermo Tellez
APAlejandro Alcántara Pineda
Alejandro Alcántara Pineda
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
The use of the USP IV apparatus (flow-through cell) has gained acceptance in recent years due to its versatility and ability to discriminate due to its hydrodynamic conditions. Therefore, the objective of the present study was to develop a discriminative dissolution method in the USP IV apparatus using the open-loop configuration, as well as to propose a method to compare non-cumulative dissolution profiles obtained in the open-loop configuration considering kinetic parameters and validate its predictive power through its comparison with independent and dependent methods using five commercial immediate-release tablet drugs (one reference drug and four generic drugs) of metoprolol tartrate as a model drug. The comparison of the non-accumulated dissolution profiles consisted of determining the geometric ratio of Cmax, AUC0∞, AUC0Cmax, and Tmax (kinetic parameters) of the generic/reference drugs, whereby generic drugs “C” and “D” presented the highest probability of similarity since their 90% confidence intervals were included, or they were very close to the acceptance interval (80.00–125.00%). These results were consistent with the f2, bootstrap f2, and dissolution efficiency approaches (independent models). In conclusion, the proposed comparison method can be an important tool to establish similarity in dissolution profiles and to facilitate the development/selection of new formulations and positively ensure bioequivalence in clinical studies.

11 September 2026 in AAPS PharmSciTech
Verified
Journal Article
Open access
PDF file
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
EMElvia Adriana Morales
Elvia Adriana Morales
CCCarla O. Contreras-Ochoa
Carla O. Contreras-Ochoa
MMMarisol Mir-Garcia
Marisol Mir-Garcia
HMHugo Cortés Martínez
Hugo Cortés Martínez
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
Curcumin (CUR) has shown promising anticancer activity against non-small cell lung cancer (NSCLC), but its poor biopharmaceutical properties limit its appl

12 October 2017 in Journal of the Mexican Chemical Society
Verified
Journal Article
Open access
PDF file
GPGuadalupe Pérez-Caballero
Guadalupe Pérez-Caballero
NMNancy Muro-Hidalgo
Nancy Muro-Hidalgo
EMElvia Adriana Morales
Elvia Adriana Morales
ALMA VILLASEÑORALMA VILLASEÑOR
ALMA VILLASEÑOR
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
A reversed phase high-performance liquid chromatography (RP-HPLC) method for determination of Thimerosal (TMS) in topical creams was optimized and validated according to the ICH guidelines which include accuracy, precision, selectivity, robustness, limit of detection (LOD), limit of quantification (LOQ), linearity and range. For topical creams, sample treatment is often an overwhelming step essentially due to its oily nature. For the first time a simple and robust extraction procedure for TMS using phosphate buffer (pH 5.5, 0.2M) was successfully developed. This method describes the TMS quantitation by HPLC in a topical product containing 0.01% fluocinolone acetonide (FLA) as the active molecule. The HPLC separation was achieved on a Column Symmetry® and a methanol: phosphate buffer (pH 2.5, 0.05M) 70:30 v/v mobile phase and wavelength 218 nm. Results from both standards and samples showed adequate validation parameters. Noteworthy, linearity was within the range 1.2 - 2.8 μg/mL. Additionally, robustness and TMS stability were established after sample extraction. The method provides an efficient and safe quality control tool for determination of TMS in topical creams.